FIBROGEN INC — Director's Dealing 2025

Mar 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-03-20

Reporting Person: Schoeneck James A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-20	Common Stock	P	250000	$0.352	Acquired	323722	Indirect
2025-03-21	Common Stock	P	50000	$0.3408	Acquired	373722	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	28766	Direct

Footnotes

F1: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3499 to $0.3593. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

F2: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.3341 to $0.3466. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.